A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide
- 1 August 1997
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 28 (4) , 157-163
- https://doi.org/10.1016/s0732-8893(97)00065-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Survey of prevalence of extended spectrum β-lactamases among EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 1996
- Meropenem: a microbiological overviewJournal of Antimicrobial Chemotherapy, 1995
- In vitro activity of three carbapenem antibiotics comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwideDiagnostic Microbiology and Infectious Disease, 1993
- Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis groupJournal of Antimicrobial Chemotherapy, 1991
- Multicenter in vitro evaluation of SM-7338, a new carbapenemAntimicrobial Agents and Chemotherapy, 1989
- Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4Antimicrobial Agents and Chemotherapy, 1989
- Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'Antimicrobial Agents and Chemotherapy, 1989
- Characterization of beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum -lactamasesJournal of Antimicrobial Chemotherapy, 1989
- In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidime against clinical isolates from West GermanyJournal of Antimicrobial Chemotherapy, 1989